Coya Therapeutics annual revenue
2022
2023
2024
2025
Coya Therapeutics Revenue Growth & History (COYA)
Coya Therapeutics reported $7.9M in revenue for fiscal 2025, an increase of 123.57% from the previous fiscal year.
View full Coya Therapeutics company overviewCoya Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.9M | $4.4M | +123.57% |
| 2024 | 2024-12-31 | $3.6M | −$2.4M | −40.79% |
| 2023 | 2023-12-31 | $6.0M | $6.0M | — |
| 2022 | 2022-12-31 | $0 | — | — |
Coya Therapeutics quarterly revenue
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $243,745 | $80,129 | +48.97% |
| Q1 2026 | 2026-03-31 | $251,147 | −$6,737 | −2.61% |
| Q4 2025 | 2025-12-31 | $4.0M | $4.0M | +202768.80% |
| Q3 2025 | 2025-09-30 | $3.6M | $3.6M | — |
| Q2 2025 | 2025-06-30 | $163,616 | −$3.3M | −95.22% |
| Q1 2025 | 2025-03-31 | $257,884 | $131,046 | +103.32% |
| Q4 2024 | 2024-12-31 | $1,952 | −$6.0M | −99.97% |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $3.4M | $3.4M | — |
| Q1 2024 | 2024-03-31 | $126,838 | $126,838 | — |
| Q4 2023 | 2023-12-31 | $6.0M | — | — |
| Q3 2023 | 2023-09-30 | $0 | — | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $0 | — | — |
Coya Therapeutics revenue growth trends
Coya Therapeutics's latest reported quarter, Q2 2026, generated $243,745 in revenue, an increase of 48.97% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Coya Therapeutics source filings ↗